Digital health companies are playing an important role in the global response to the COVID-19 public health emergency.  For example, the White House Office of Science and Technology Policy issued a Call to Action to the tech community requesting help in answering urgent scientific questions about COVID-19.  As readers of this blog are aware, some digital health solutions are regulated as medical devices.  Recently, Covington put together a briefing on the regulatory considerations for medical device companies as they prepare to respond to the COVID-19 pandemic.  Digital health companies might be interested in slides 35 to 39, which specifically address considerations for COVID-19 digital health solutions that are regulated as medical devices in the U.S.:  Access the Full Presentation Here